Companies›Commodities›Chemicals›Chemicals & Petrochemicals
NSE:PRIVISCL

PRIVI SPECIALITY CHE LTD

Chemicals › Chemicals & Petrochemicals·NIFTY 500NIFTY MIDSMALLCAP 400NIFTY MIDSMALLCAP400 50:50NIFTY SMALLCAP 250+4
₹3,474.90
at close · 28 Oct 2026
▼ 65.10 (-1.84%)

Latest filings

Next results: Thu, 29 Oct · Financial Results/Dividend
  1. Shareholders approve amalgamation of two Privi group companies · Compliance
  2. Privi shareholders approve merger of two private companies · Strategic Transactions
  3. Privi to discuss September quarter and half-year results on October 30 · Board & Shareholder Meetings
All filings ↓
Ask Nexa about PRIVI SPECIALITY CHE LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Manufactures specialty aroma chemicals — fragrance and flavour ingredients — for global fragrance and flavour (F&F) customers. As of FY26, the company describes aroma chemicals as its sole product line, though historical segment reporting had also covered oleo chemicals and intermediate neutraceuticals (10.9% of segment revenue in the quarter ended June 2020, with aroma chemicals at 89.1%). FY26 revenue was Rs 2,582.92 cr with net profit of Rs 316.72 cr. Exports contributed roughly two-thirds of revenue, and named customers include Givaudan, IFF, Symrise and P&G. Capacity is being expanded in phases through FY28 alongside the addition of specialty products such as Maltol, Ethyl Maltol, Musk T and Cyclopentadecanone. A joint venture with Jubilant (PRIGIV) turned profitable in Q4 FY26, and a three-way merger of subsidiaries with the parent is targeted for completion within FY27.

Revenue mix · reported segments
Aroma Chemicals89.1%
Oleo Chemicals and Intermediate Neutraceuticals10.9%
Operating scale
Current production capacity
48,000 MTFY26
Phase 1 capacity target
54,000 MT~Sep 2026
Total capacity target post Phase 1-3
72,000 MT~Jun-Sep 2028
Exports share of revenue
66-67%FY26
FY26 EBITDA margin
25.76%FY26
Planned capex
Rs 850-900 crFY27-FY29
Who pays it
Global fragrance and flavour houses including Givaudan, IFF, Symrise and P&G
Biggest cost
Raw materials at 52.9% of revenue
Kind of business
Specialty, asset-heavy chemicals with capacity-led growth
Where it sits
India-based specialty aroma chemicals exporter serving global F&F majors
Market Cap
₹13,574 Cr
P / E (TTM)
38.8×
EV / EBITDA
21.0×
Div Yield
0.14%
Growth
15.0%▲
Revenue 5y CAGR
PAT +22.1% · EBITDA +21.6%
Quality
15.8%▲
ROCE (5y median)
ROE 11.9% (5y median) · margin 26.0%
Leverage
0.70·
Debt / Equity · moderate
Net debt ₹966 Cr
Revenue FY21→FY26
2.0×▲
Margin +3.2 pts
₹1,277 Cr → ₹2,564 Cr
Cash conversion
1.73×▲
Operating cash ÷ profit · 5 yrs
₹1,239 Cr on ₹716 Cr
Moves on a normal day
1.05%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 107 Specialty Chemicals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#73/99
P/B#92/99
ROCE#15/106
ROE#9/99
Debt / Equity#86/99
EBITDA margin#25/99
Revenue growth#55/94
Profit growth#50/92

Scorecard

Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice

Strengths
Revenue compounding 15% a year over 5 years
Profit compounding 22% a year over 5 years
Returns on capital 15.8% (5-year median)
#15 of 106 in Specialty Chemicals on the latest reported figures · up from 16.5% in FY21
Over 5 years it reported ₹716 Cr of profit and ₹1,239 Cr of operating cash — 1.73×
Profit is converting into cash
Concerns
Carries more debt than its peers — 0.70× equity
higher than 87% of its 99 Specialty Chemicals peers

Charts

How has the market priced it — with filings on the timeline?

PRIVISCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from PRIVI SPECIALITY CHE LTD's filed financials and exchange disclosures

What does PRIVI SPECIALITY CHE LTD do?

PRIVI SPECIALITY CHE LTD is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol PRIVISCL.

Is PRIVI SPECIALITY CHE LTD profitable?

Yes. Over the trailing twelve months PRIVI SPECIALITY CHE LTD reported a net profit of ₹342 Cr on revenue of ₹2,671 Cr.

Does PRIVI SPECIALITY CHE LTD pay a dividend?

Yes. The dividend yield is 0.14% at the current price. It paid out 6% of its profit as dividend in FY26.

Is PRIVI SPECIALITY CHE LTD debt-free?

No. It reported borrowings of ₹1,010 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹966 Cr after cash. Debt stands at 0.70× equity. That is higher than 87% of its 99 Specialty Chemicals peers.

Is PRIVI SPECIALITY CHE LTD expensive compared with its peers?

On trailing P/E, PRIVI SPECIALITY CHE LTD ranks 73 of 99 in Specialty Chemicals — cheaper than 27% of them, against an industry median of 23.1×. This is a position, not a valuation judgement.

How much does the PRIVI SPECIALITY CHE LTD share price move in a day?

On a typical session PRIVI SPECIALITY CHE LTD moves 1.05% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are PRIVI SPECIALITY CHE LTD's next results?

Financial Results/Dividend on Thu, 29 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track PRIVI SPECIALITY CHE LTD's announcements?

Every NSE and BSE filing by PRIVI SPECIALITY CHE LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.